US2019201310A1PendingUtilityA1
Oral care composition
Assignee: Next Science IP Holdings Pty LtdPriority: Oct 8, 2011Filed: Nov 15, 2018Published: Jul 4, 2019
Est. expiryOct 8, 2031(~5.2 yrs left)· nominal 20-yr term from priority
Inventors:Matthew F. Myntti
A61K 8/4926A61P 31/04A01N 61/00A61K 8/463A61Q 17/005A61K 8/55A61K 31/19A61K 8/19A61K 8/44A61K 8/365A61K 8/416A61P 17/02A61K 8/466A61K 31/14A61K 31/194A01N 59/00A61K 8/39A61K 33/00A61K 8/41A61K 8/602A61K 8/37A61K 8/4973A01N 59/26A61K 47/02A61Q 11/00A61K 33/42A61K 33/20A61K 9/0014A61K 8/347A61K 33/32A01N 37/36A01N 25/30A61K 47/10A61K 9/08A61K 9/06A61K 33/02A61K 8/86A61K 8/34A61K 9/0063A61L 26/0066A61L 2300/404A61K 33/04A01N 25/02A01N 25/08A01N 41/04A61K 8/498A61K 47/12A61K 47/34A61K 33/24
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.
Claims
exact text as granted — not AI-modifiedThat which is claimed is:
1 . An oral care composition useful for treating a microbe-induced condition of the oral cavity of a subject in need thereof, said oral care composition consisting of (1) an oral rinse containing eucalyptol, thymol, menthol, and methyl salicylate in an alcohol vehicle, (2) an aqueous composition consisting of dissociation products of at least one acid and at least one salt of an acid in water, and (3) from 0.5 to 1.8 g/L of at least one surfactant.
2 . The oral care composition of claim 1 having an osmolarity of at least about 300 mOsm/L.
3 . The oral care composition of claim 2 having an osmolarity of at least about 500 mOsm/L.
4 . The oral care composition of claim 3 having an osmolarity of at least about 700 mOsm/L.
5 . The oral care composition of claim 1 wherein said at least one surfactant comprises a non-ionic surfactant.
6 . The oral care composition of claim 1 wherein said at least one surfactant is a non-ionic surfactant.
7 . The oral care composition of claim 1 wherein said at least one surfactant comprises an ionic surfactant.
8 . The oral care composition of claim 1 wherein said at least one surfactant is an ionic surfactant.
9 . The oral care composition of claim 8 wherein said cationic surfactant is present at from 0.75 to 1.5 g/L.
10 . The oral care composition of claim 9 having an osmolarity of at least about 300 mOsm/L.
11 . The oral care composition of claim 10 having an osmolarity of at least about 500 mOsm/L.
12 . The oral care composition of claim 11 having an osmolarity of at least about 700 mOsm/L.
13 . The oral care composition of claim 1 wherein said surfactant is present at from 0.75 to 1.5 g/L.
14 . The oral care composition of claim 13 having an osmolarity of at least about 300 mOsm/L.
15 . The oral care composition of claim 14 having an osmolarity of at least about 500 mOsm/L.
16 . The oral care composition of claim 15 having an osmolarity of at least about 700 mOsm/L.
17 . A process for treating a microbe-induced condition of the oral cavity of a subject in need thereof, said process comprising administering to said subject the oral care composition of claim 1 .
18 . The process of claim 17 wherein said oral care composition has an osmolarity of at least about 300 mOsm/L.
19 . The process of claim 18 wherein said oral care composition has an osmolarity of at least about 500 mOsm/L.
20 . The process of claim 18 wherein said oral care composition has an osmolarity of at least about 700 mOsm/L.Join the waitlist — get patent alerts
Track US2019201310A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.